Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates

被引:37
作者
Blackhall, FH
Merry, CLR [1 ]
Lyon, M
Jayson, GC
Folkman, J
Javaherian, K
Gallagher, JT
机构
[1] Univ Manchester, Dept Med Oncol, Canc Res UK, Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Surg, Boston, MA 02115 USA
关键词
angiogenesis; endostatin; heparin sulphate; oligosaccharide; sulphation;
D O I
10.1042/BJ20030730
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endostatin is a naturally occurring proteolytic fragment of the C-terminal domain of colla-en XVIII. It inhibits angiogenesis by a mechanism that appears to involve binding to HS (heparan sulphate). We have examined the molecular interaction between endostatin and HS from micro- and macrovessel endothelial cells. Two discrete panels of oligosaccharides were prepared from metabolically radiolabelled HS, using digestion with either heparinase I or III. and then examined for their endostatin affinity using a sensitive filter-binding assay. Two types of endostatin-binding regions,were identified: one comprising sulphated domains of five or more disaccharides in length, enriched in 6-O-sulphate groups, and the other contained long heparinase I-resistant fragments. In the latter case, evidence from the present study suggests that the binding region encompasses a sulphated domain fragment and a transition zone of intermediate sulphation. The contribution to binding of specific O-sulphate groups was determined using selectively desulphated HS species, namely HS from Hs2st(-/-) mutant cells, and by comparing the compositions of endostatin-binding and non-binding oligosaccharides. The results indicate that 6-O-sulphates play a dominant role in site selectivity and 2-O-sulphates are not strictly essential.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 29 条
[21]   Heparan sulfate: A piece of information [J].
Salmivirta, M ;
Lidholt, K ;
Lindahl, U .
FASEB JOURNAL, 1996, 10 (11) :1270-1279
[22]   Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin [J].
Sasaki, T ;
Fukai, N ;
Mann, K ;
Göhring, W ;
Olsen, BR ;
Timpl, R .
EMBO JOURNAL, 1998, 17 (15) :4249-4256
[23]   Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin [J].
Sasaki, T ;
Larsson, H ;
Kreuger, J ;
Salmivirta, M ;
Claesson-Welsh, L ;
Lindahl, U ;
Hohenester, E ;
Timpl, R .
EMBO JOURNAL, 1999, 18 (22) :6240-6248
[24]   Inhibitory effect of full-length human endostatin on in vitro angiogenesis [J].
Taddei, L ;
Chiarugi, P ;
Brogelli, L ;
Cirri, P ;
Magnelli, L ;
Raugei, G ;
Ziche, M ;
Granger, HJ ;
Chiarugi, V ;
Ramponi, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) :340-345
[25]  
TURNBULL JE, 1992, J BIOL CHEM, V267, P10337
[26]   SEQUENCE-ANALYSIS OF HEPARAN-SULFATE INDICATES DEFINED LOCATION OF N-SULFATED GLUCOSAMINE AND IDURONATE 2-SULFATE RESIDUES PROXIMAL TO THE PROTEIN-LINKAGE REGION [J].
TURNBULL, JE ;
GALLAGHER, JT .
BIOCHEMICAL JOURNAL, 1991, 277 :297-303
[27]   METHOD FOR DETERMINATION OF MOLECULAR WEIGHT AND MOLECULAR-WEIGHT DISTRIBUTION OF CHONDROITIN SULPHATE [J].
WASTESON, A .
JOURNAL OF CHROMATOGRAPHY, 1971, 59 (01) :87-&
[28]  
YAMADA SH, 1993, J BIOL CHEM, V268, P4780
[29]   Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding [J].
Yamaguchi, N ;
Anand-Apte, B ;
Lee, M ;
Sasaki, T ;
Fukai, N ;
Shapiro, R ;
Que, I ;
Lowik, C ;
Timpl, R ;
Olsen, BR .
EMBO JOURNAL, 1999, 18 (16) :4414-4423